Oragenics Inc. Files 8-K Report

Ticker: OGEN · Form: 8-K · Filed: Aug 8, 2024 · CIK: 1174940

Sentiment: neutral

Topics: sec-filing, 8-k, financials

Related Tickers: ORGN

TL;DR

ORGN filed an 8-K, likely with financial updates. Keep an eye out for details.

AI Summary

On August 8, 2024, Oragenics, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This filing signals that Oragenics, Inc. is providing updated information to the SEC, which could include material events or financial disclosures relevant to investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification and does not contain specific financial or operational risks.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing for Oragenics, Inc.?

The filing is primarily for "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and significant occurrences.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported is August 8, 2024.

What is Oragenics, Inc.'s principal executive office address?

The principal executive office address is 1990 Main Street Suite 750 Sarasota, FL 34236.

What is the telephone number for Oragenics, Inc.?

The registrant's telephone number, including area code, is 813 - 286-7900.

What is Oragenics, Inc.'s state of incorporation and IRS Employer Identification Number?

Oragenics, Inc. is incorporated in Florida (FL) and its IRS Employer Identification Number is 59-3410522.

Filing Stats: 449 words · 2 min read · ~1 pages · Grade level 11.2 · Accepted 2024-08-08 08:30:19

Filing Documents

SIGNATURES

SIGNATURES In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on this 8 th day of August, 2024. ORAGENICS, INC. (Registrant) BY: /s/ Janet Huffman Janet Huffman Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing